Literature DB >> 19339747

Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization.

Hiroshi Mochimaru1, Eri Takahashi, Nobuo Tsukamoto, Junichiro Miyazaki, Tomonori Yaguchi, Takashi Koto, Toshihide Kurihara, Kousuke Noda, Yoko Ozawa, Takatsugu Ishimoto, Yutaka Kawakami, Hidenobu Tanihara, Hideyuki Saya, Susumu Ishida, Kazuo Tsubota.   

Abstract

PURPOSE: CD44 is a cell-surface adhesion molecule and receptor for hyaluronan (HA), one of the major extracellular matrix components. The purpose of the present study was to clarify a role of HA and CD44 in the development of choroidal neovascularization (CNV).
METHODS: Laser photocoagulation was used to induce CNV in C57BL/6 mice or CD44-deficient mice. The mRNA expression of CD44 and HA synthase (HAS)-2 in the retinal pigment epithelium (RPE)-choroid complex was evaluated by DNA microarray and real-time RT-PCR analyses 3 days after laser treatment. HA synthesis and CD44 expression were examined by immunohistochemistry 1 week after photocoagulation. Mice with laser-induced CNV were systemically administered the HA synthesis inhibitor 4-methylumbelliferone (MU) or an anti-CD44-neutralizing antibody. The response of CNV was analyzed by volumetric measurements 1 week after photocoagulation. Macrophage infiltration into CNV lesions was evaluated by real-time RT-PCR for F4/80 3 days after laser-induced injury.
RESULTS: The induction of CNV led to a significant increase in expression of CD44 and HAS2 mRNA. HA and CD44 were immunopositive in the CNV lesions. Compared with vehicle treatment, the systemic application of MU significantly attenuated CNV volume in a dose-dependent fashion, together with macrophage infiltration into the lesions. Consistently, antibody-based blockade of CD44 resulted in a significant reduction of CNV volume, compared with the isotype control. In contrast, genetic ablation of CD44 significantly augmented CNV formation together with HA accumulation and macrophage infiltration, compared with wild-type mice.
CONCLUSIONS: These results indicate a significant role of HA and its receptor CD44 in the development of CNV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339747     DOI: 10.1167/iovs.08-3044

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  Platelet-derived growth factor-DD targeting arrests pathological angiogenesis by modulating glycogen synthase kinase-3beta phosphorylation.

Authors:  Anil Kumar; Xu Hou; Chunsik Lee; Yang Li; Arvydas Maminishkis; Zhongshu Tang; Fan Zhang; Harald F Langer; Pachiappan Arjunan; Lijin Dong; Zhijian Wu; Linda Y Zhu; Lianchun Wang; Wang Min; Peter Colosi; Triantafyllos Chavakis; Xuri Li
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

2.  CD44 isoforms in human retinal and choroidal endothelial cells.

Authors:  Timothy J Chipps; Binoy Appukuttan; Yuzhen Pan; Justine R Smith
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-03       Impact factor: 3.117

3.  Hyaluronan-Conjugated Carbon Quantum Dots for Bioimaging Use.

Authors:  Bedia Begüm Karakoçak; Amine Laradji; Tina Primeau; Mikhail Y Berezin; Shunqiang Li; Nathan Ravi
Journal:  ACS Appl Mater Interfaces       Date:  2020-12-23       Impact factor: 9.229

4.  Quantitative assessment of CD44 genetic variants and cancer susceptibility in Asians: a meta-analysis.

Authors:  Vishal Chandra; Yun-Mi Lee; Usha Gupta; Balraj Mittal; Jong Joo Kim; Rajani Rai
Journal:  Oncotarget       Date:  2016-11-08

5.  Inhibition of YAP ameliorates choroidal neovascularization via inhibiting endothelial cell proliferation.

Authors:  Zhenzhen Yan; Haihong Shi; Rongrong Zhu; Lele Li; Bai Qin; Lihua Kang; Hui Chen; Huaijin Guan
Journal:  Mol Vis       Date:  2018-01-31       Impact factor: 2.367

6.  Transcriptomic analysis of choroidal neovascularization reveals dysregulation of immune and fibrosis pathways that are attenuated by a novel anti-fibrotic treatment.

Authors:  Alice Brandli; Fay L Khong; Roy C K Kong; Darren J Kelly; Erica L Fletcher
Journal:  Sci Rep       Date:  2022-01-17       Impact factor: 4.379

7.  Hyaluronic-Coated Albumin Nanoparticles for the Non-Invasive Delivery of Apatinib in Diabetic Retinopathy.

Authors:  Salma El-Sayed Radwan; Amal El-Kamel; Eiman I Zaki; Susi Burgalassi; Erica Zucchetti; Riham M El-Moslemany
Journal:  Int J Nanomedicine       Date:  2021-07-02

8.  VEGF receptor blockade markedly reduces retinal microglia/macrophage infiltration into laser-induced CNV.

Authors:  Hu Huang; Rachel Parlier; Ji-Kui Shen; Gerard A Lutty; Stanley A Vinores
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

Review 9.  Directional protein secretion by the retinal pigment epithelium: roles in retinal health and the development of age-related macular degeneration.

Authors:  Paul Kay; Yit C Yang; Luminita Paraoan
Journal:  J Cell Mol Med       Date:  2013-05-11       Impact factor: 5.310

10.  Role of FGF and Hyaluronan in Choroidal Neovascularization in Sorsby Fundus Dystrophy.

Authors:  Alyson Wolk; Dilara Hatipoglu; Alecia Cutler; Mariya Ali; Lestella Bell; Jian Hua Qi; Rupesh Singh; Julia Batoki; Laura Karle; Vera L Bonilha; Oliver Wessely; Heidi Stoehr; Vincent Hascall; Bela Anand-Apte
Journal:  Cells       Date:  2020-03-04       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.